In this research, we conducted a pan-cancer analysis to examine the link between ALG3 expression, patient prognosis, immunological milieu, microsatellite instability (MSI) immune checkpoint genes, tumor mutation burden (TMB), and immunological neoantigens in 33 cancers. Here, ALG3 is linked to cancer.